Genitourinary Radiology: Page 6

When is the best time to stop following low-risk prostate cancer?
By AuntMinnieEurope.com staff writers
There are a variety of factors associated with the discontinuation of active surveillance of men with low-risk prostate cancer, both demographic and clinical, according to a study published August 20 in the Journal of Urology.
August 22, 2021
2020 07 15 23 29 3710 Cancer Cells Prostate 400
Karolinska team seeks to optimize prostate cancer screening
By Kate Madden Yee
Scientists from the Karolinska Institute in Stockholm have used a new type of blood test to screen for prostate cancer to reduce unnecessary MRI scans by 36% and avoid overdiagnosis. Their study was posted on 12 August in Lancet Oncology.
August 15, 2021
2020 12 22 16 54 5551 Karolinska Institute Entrance 400
MRI for prostate cancer screening reduces unnecessary biopsies
By Kate Madden Yee
Swedish researchers have found that using MRI for prostate cancer screening finds clinically significant cancer and reduces unnecessary biopsies, according to a study published on 9 July in the New England Journal of Medicine.
July 18, 2021
Swedish MRI study adds momentum to prostate cancer screening
By Kate Madden Yee
A group from the Karolinska in Stockholm has reported that using MRI for prostate cancer screening finds clinically significant cancer and reduces unnecessary biopsies. The team published its results on 9 July in the New England Journal of Medicine.
July 13, 2021
2021 07 13 16 11 0027 Prostate Cancer 400
AI can enhance identification of kidney stones on CT scans
By Erik L. Ridley
Investigators from the University of Turgut Ozal in Malatya, Turkey, have developed an artificial intelligence (AI) algorithm to detect and localize kidney stones on noncontrast CT exams. The algorithm yielded 96.8% accuracy in testing and was deemed to be ready for clinical use.
June 22, 2021
2016 08 23 17 04 30 620 Kidney 400
Groups launch registry to promote SPECT for prostate cancer
By AuntMinnieEurope.com staff writers
The Oncidium Foundation and Telix Pharmaceuticals have launched a registry to promote the use of SPECT with a prostate-specific membrane antigen agent for prostate cancer detection.
April 20, 2021
2016 10 04 11 38 34 158 Prostate 400
Quantib secures CE Mark for prostate MRI software
By AuntMinnieEurope.com staff writers
Artificial intelligence (AI) software developer Quantib has secured the CE Mark for its Quantib Prostate package for prostate MRI interpretation.
April 8, 2021
2016 10 04 11 38 34 158 Prostate 400
Early prostate MRI scans can help reduce mortality rates
By Kate Madden Yee
Researchers from University College London have reported that performing MRI scans before biopsy on men with high prostate-specific antigen scores could cut prostate cancer death rates by as much as 18% versus no screening, while also minimizing the harms of screening.
March 14, 2021
2021 03 15 18 14 1275 Mri Prostate 400
Imaging proves vital when assessing COVID-19 kidney complications
By Kate Madden Yee
Imaging plays a central role in evaluating and tracking kidney complications due to COVID-19 -- and radiologists must not only understand what to look for but also make themselves readily available to their referring colleagues, Italian experts told ECR 2021 attendees.
March 10, 2021
2021 03 11 17 45 5637 2021 03 11 Ecr Renal Covid Image1 20210311171748
Telix secures Czech approval for prostate PET radiopharmaceutical
By AuntMinnieEurope.com staff writers
Telix Pharmaceuticals has received approval from the Czech Republic's Ministry of Health for use of its Illuccix radiopharmaceutical for prostate cancer PET imaging in that country.
February 18, 2021
2021 02 19 01 09 5836 Cancer Cells Prostate 400
French groups issue new guidelines to promote safe contrast use
By Frances Rylands-Monk
French nephrology societies and the national radiology society have published guidelines on the safe use of contrast media in the wake of guidance from the European Society of Urogenital Radiology.
February 14, 2021
2021 02 12 17 02 4497 French Flag Splashes 400
U.K. team backs shorter MRI exam for prostate cancer screening
By Kate Madden Yee
A research team from Imperial College London has reported that a short, biparametric MRI protocol without contrast detected twice as many clinically significant prostate cancers compared with prostate-specific antigen (PSA) testing. The authors published their results on 11 February in JAMA Oncology.
February 14, 2021
2021 02 12 16 33 4471 3 D Prostate Cancer Viral 400
Previous Page
Page 6 of 22
Next Page